Juvenile cancer patients from northern Israel will receive funding for a life-prolonging experimental drug, according to Israel Defense Forces Radio.
Professor Miriam Ben Harosh, director of the Rambam Children's Hospital in Haifa, said "I am sure that in a few years we will prove, thanks to these treatments, that we will be able to raise the healing rate of children with cancer."